Antidote
DECEMBER 29, 2022
Generally, a doctor’s visit is intended to provide clarity and insight into a patient’s concerns — but many people are all too familiar with the feeling of walking out of a clinic more confused than when they arrived. In fact, many Americans find themselves searching for health literacy tips after becoming confused by a doctor’s instructions or the directions on a prescription label.
ProRelix Research
DECEMBER 27, 2022
Clinical trials form the crux of all regulatory decisions regarding any new health intervention such as drugs and medical devices and thus require to be performed with the utmost care […]. The post USA Clinical Trial Market Size and Opportunities appeared first on ProRelix Research.
Drug Patent Watch
DECEMBER 26, 2022
Annual Drug Patent Expirations for VICTOZA Victoza is a drug marketed by Novo Nordisk Inc and is included in one NDA. It is available from two suppliers. There are seven…. The post New patent expiration for Novo Nordisk drug VICTOZA appeared first on DrugPatentWatch - Make Better Decisions.
Cytel
DECEMBER 29, 2022
Perspectives on Enquiry and Evidence explores a wide variety of topics within clinical trial design and data science in the form of expert articles, interviews, ebooks, and more. Here are some of our most read posts of 2022.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Antidote
DECEMBER 27, 2022
Though clinical trials as we know them have only existed since the 1980s , the past 40 years have been ripe with innovations in the process. From an increased focus on the patient experience to the rise of clinical trial matching software, the world of medical research continues to grow and evolve.
New Drug Approvals
DECEMBER 26, 2022
(Heavy chain) QVQLVQSGAE VKKPGSSVMV SCQASGGLLE DYIINWVRQA PGQGPEWMGG IIPVLGTVHY GPKFQGRVTI TADESTDTAY MELSSLRSED TAMYYCATET ALVVSETYLP HYFDNWGQGT LVTVSSASTK GPSVFPLAPS SKSTSGGTAA LGCLVKDYFP EPVTVSWNSG ALTSGVHTFP AVLQSSGLYS LSSVVTVPSS SLGTQTYICN VNHKPSNTKV DKRVEPKSCD KTHTCPPCPA PELLGGPSVF LFPPKPKDTL YITREPEVTC VVVDVSHEDP EVKFNWYVDG VEVHNAKTKP REEQYNSTYR VVSVLTVLHQ DWLNGKEYKC KVSNKALPAP IEKTISKAKG QPREPQVYTL PPSREEMTKN QVSLTCLVKG FYPSDIAVEW ESNGQPENNY KTTPPVLDSD GSFFLYSKLT VDKSRWQQGN VFSCSVMHEA LH
Drug Discovery Digest brings together the best content for drug research and development professionals from the widest variety of industry thought leaders.
Cytel
DECEMBER 27, 2022
Bayesian methods have been playing a key role in transforming clinical research, providing a variety of new opportunities for efficient and flexible clinical trials. Bayesian topics are frequently explored in Perspectives on Enquiry and Evidence. Here are some of our most-read articles on Bayesian methods in 2022.
Drug & Device Law
DECEMBER 27, 2022
What follows is from the non-Dechert side of the Blog. In the Zantac MDL, the plaintiffs’ causation problems were plainly visible on the horizon, as we mentioned in our post last year about the Zantac ruling on medical monitoring, In re Zantac (Ranitidine) Products Liability Litigation , 546 F. Supp.3d 1152 (S.D. Fla. 2021). The Zantac MDL plaintiffs’ claims regarding risk of injury and exposure levels to purported ranitidine-derived nitrosamines (“NDMA” for short) seemed not only trivial, but
Drug Patent Watch
DECEMBER 30, 2022
Annual Drug Patent Expirations for RHOFADE Rhofade is a drug marketed by Epi Hlth and is included in one NDA. It is available from one supplier. There are seven patents…. The post New patent for Epi Hlth drug RHOFADE appeared first on DrugPatentWatch - Make Better Decisions.
Drug Patent Watch
DECEMBER 29, 2022
This chart shows the pharmaceutical companies with the most gel dosed drugs. For a different perspective, see the most popular dosage types. The companies with the most gel dosed drugs…. The post Which pharmaceutical companies have the most gel dosed drugs? appeared first on DrugPatentWatch - Make Better Decisions.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Drug Patent Watch
DECEMBER 29, 2022
[
Drug Patent Watch
DECEMBER 29, 2022
[
Drug Patent Watch
DECEMBER 28, 2022
This chart shows the drugs with the most patents in Croatia. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…. The post Which pharmaceutical drugs have the most drug patents in Croatia? appeared first on DrugPatentWatch - Make Better Decisions.
Drug Patent Watch
DECEMBER 28, 2022
Annual Drug Patent Expirations for ZONISADE Zonisade is a drug marketed by Azurity and is included in one NDA. It is available from one supplier. There is one patent protecting…. The post New patent for Azurity drug ZONISADE appeared first on DrugPatentWatch - Make Better Decisions.
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
Drug Patent Watch
DECEMBER 27, 2022
This chart shows the pharmaceutical companies with the most patents in Denmark. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…. The post Which pharmaceutical companies have the most drug patents in Denmark? appeared first on DrugPatentWatch - Make Better Decisions.
Drug Patent Watch
DECEMBER 27, 2022
Annual Drug Patent Expirations for TASCENSO+ODT Tascenso Odt is a drug marketed by Handa and is included in one NDA. There are three patents protecting this drug. This drug has…. The post New patent for HANDA drug TASCENSO ODT appeared first on DrugPatentWatch - Make Better Decisions.
Drug Patent Watch
DECEMBER 26, 2022
This chart shows the pharmaceutical companies with the most emulsion dosed drugs. For a different perspective, see the most popular dosage types. The companies with the most emulsion dosed drugs…. The post Which pharmaceutical companies have the most emulsion dosed drugs? appeared first on DrugPatentWatch - Make Better Decisions.
Drug Patent Watch
DECEMBER 26, 2022
[
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
Drug Patent Watch
DECEMBER 26, 2022
[
Drug Patent Watch
DECEMBER 26, 2022
VICTOZA (liraglutide recombinant) Novo nordisk inc Patent: 8,846,618 Expiration: Dec 27, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact…. The post Drug Patent Expirations for the Week of December 25, 2022 appeared first on DrugPatentWatch - Make Better Decisions.
Drug Patent Watch
DECEMBER 26, 2022
Annual Drug Patent Expirations for SAXENDA Saxenda is a drug marketed by Novo and is included in one NDA. It is available from two suppliers. There are twenty-five patents protecting…. The post New patent expiration for NOVO drug SAXENDA appeared first on DrugPatentWatch - Make Better Decisions.
Drug Patent Watch
DECEMBER 25, 2022
This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Finland. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…. The post Which pharmaceutical companies have the most SPCs in Finland? appeared first on DrugPatentWatch - Make Better Decisions.
Drug Patent Watch
DECEMBER 24, 2022
This chart shows the pharmaceutical companies with the most lotion dosed drugs. For a different perspective, see the most popular dosage types. The companies with the most lotion dosed drugs…. The post Which pharmaceutical companies have the most lotion dosed drugs? appeared first on DrugPatentWatch - Make Better Decisions.
Drug Patent Watch
DECEMBER 24, 2022
Annual Drug Patent Expirations for ANJESO Anjeso is a drug marketed by Baudax and is included in one NDA. There are eight patents protecting this drug. Drug patent litigation for…. The post New patent expiration for Baudax drug ANJESO appeared first on DrugPatentWatch - Make Better Decisions.
Drug Patent Watch
DECEMBER 30, 2022
[
Drug Patent Watch
DECEMBER 30, 2022
[
Drug Patent Watch
DECEMBER 28, 2022
[
Drug Patent Watch
DECEMBER 28, 2022
[
Drug Patent Watch
DECEMBER 27, 2022
[
Drug Patent Watch
DECEMBER 25, 2022
[
Drug Patent Watch
DECEMBER 25, 2022
[
Expert insights. Personalized for you.
98 
Let's personalize your content